|
|
|
|
MATHYS MATTERS August 2025 |
|
Welcome to Mathys Matters - your monthly update from Mathys & Squire, covering all the recent intellectual property and sector news/updates throughout August!
This month we are shining a spotlight on the rise in use of biotherapeutic molecules in the cosmetic industry, with an analysis of the relevant patent filings worldwide.
Our latest news and articles throughout August include: ''Aligning AI Innovation with IP Strategy in Drug Discovery", "Feeding Innovation: IP, UPFs and Leaner Food Labels", "UK Government launches consultation on Standard Essential Patents", "Speak Now (or Forever Lose Your Rights): Taylor Swift’s ‘Life of a Showgirl’ and continued IP Strategy" and more.
Scroll down to read more! |
|
|
|
|
|
|
SPOTLIGHT OF THE MONTH
- The Line Between Beauty and Therapy I: Patent Strategies for Biotherapeutic Cosmetics - |
|
|
The use of biotherapeutic molecules in the cosmetic industry is growing and consumers are becoming increasingly familiar with buzzwords like “stem cells”, “exosomes” and “polynucleotides”, which were traditionally confined to medical and pharmaceutical settings. |
|
As a result of this trend, there has been an increase in the number of patent applications being filed across the globe in the field of “biotherapeutic cosmetics”. |
|
In the first article of this two-part series, Partner Samantha Moodie and Associate Clare Pratt highlight the most popular biotherapeutic molecules being used in cosmetics, examine data demonstrating the increase of related active published patent filings, and provide advice on how to best utilise IP in this increasingly competitive industry.
Click here to read more |
|
|
|
|
|
|
Aligning AI Innovation with IP Strategy in Drug Discovery 5 August
Associate Rogen Leung and Managing Associate Markus von Rudno examine the cutting-edge application of AI for structural biology, target identification and drug design, as well as the complicated implications for intellectual property strategy, including both the patentability of AI models and the ownership of AI-designed drugs.
Read the article here |
| UK Government launches consultation on Standard Essential Patents 14 August
On 15th July 2025, the UK Government published a consultation on standard essential patents (SEPs) aiming to gather feedback from interested parties. In this article, Associate Michael Charlton discusses aspects of the current SEP ecosystem and considers whether the government's suggestions will be successful.
Read the article here |
| |
| Feeding Innovation: IP, UPFs and Leaner Food Labels 11 August
With a growing demand from consumers for food products to include shorter labels and fewer ingredients, Managing Associate Matthew Morton examines consumer behaviour, the role of food processing in addressing these trends, and the importance of IP in supporting innovation and maintaining an edge against competitors.
Read the article here |
| Speak Now (or Forever Lose Your Rights): Taylor Swift’s ‘Life of a Showgirl’ and continued IP Strategy 22 August
In this article, Trainee Trade Mark Attorney Tanya Rahman and Partner Claire Breheny highlight how Taylor Swift emphasises the importance for musicians to claim ownership of their personal brand, and how such a forward-thinking strategy tactically anticipates inevitable threats of unauthorised use.
Read the article here |
| Empowering Future Professionals: Career Ready Interns at Mathys & Squire 1 August
For four weeks, we were joined by students Mahfuz Ahmed, Ejiro Williams and Mubarak Ahmed in our London Office, through our partnership with Career Ready.
Read the article here |
|
|
|
|
|
|
|
NEW PODCAST EPISODE
- Two Years of the UPC: Uncovering Patent Litigation in Europe | Nicholas Fox - |
|
|
In “Two Years of the UPC: Uncovering Patent Litigation in Europe,” host Andrew White speaks with Nicholas about his expertise in patent litigation, focusing on the Unitary Patent system. |
|
They reflect on how the landscape of patent litigation in Europe has shifted over the last couple of years, combining a detailed analysis of the data, from the volume of cases to the number of Unitary Patents filed in each sector, with astute insights on the system’s up- and downsides.
Click here to watch the full episode on YouTube or Spotify. |
|
|
|
|
|
|
|
Mathys & Squire T: +44 (0)20 7830 0000 E: info@mathys-squire.com
@Mathys_Squire www.mathys-squire.com
If you no longer wish to receive emails from us, click here to unsubscribe. |
|
